As expected, we observed similar survival and tumor burden of these CD8-low Luc90-CAR-T and ΔCS1- Luc-90-CAR-T in vivo (Fig. 3E, F) and similar to our previous experiment (Fig. S4). Here, CD8A is linked to neoplasm.